Literature DB >> 15633231

Polymerase chain reaction-single strand conformational polymorphism analysis of rearranged during transfection proto-oncogene in Chinese familial Hirschsprung's disease.

Tao Guan1, Ji-Cheng Li, Min-Ju Li, Jin-Fa Tou.   

Abstract

AIM: To investigate the relationship between mutations of rearranged during transfection (RET) proto-oncogene and Chinese patients with Hirschsprung's disease (HD), and to elucidate the genetic mechanism of familial HD patient at the molecular level.
METHODS: Genomic DNA was extracted from venous blood of probands and their relatives in two genealogies. Polymerase chain reaction (PCR) products, which were amplified using specific primers (RET, exons 11, 13, 15 and 17), were electrophoresed to analyze the single-strand conformational polymorphism (SSCP) patterns. The positive amplified products were sequenced. Forty-eight sporadic HD patients and 30 normal children were screened for mutations of RET proto-oncogene simultaneously.
RESULTS: Three cases with HD in one family were found to have a G heterozygous insertion at nucleotide 18,974 in exon 13 of RET cDNA (18,974insG), which resulted in a frameshift mutation. In another family, a heterozygosity for T to G transition at nucleotide 18,888 in the same exon which resulted in a synonymous mutation of Leu at codon 745 was detected in the proband and his father. Eight RET mutations were confirmed in 48 sporadic HD patients.
CONCLUSION: Mutations of RET proto-oncogene may play an important role in the pathogenesis of Chinese patients with HD. Detection of mutated RET proto-oncogene carriers may be used for genetic counseling of potential risk for HD in the affected families.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633231      PMCID: PMC4205417          DOI: 10.3748/wjg.v11.i2.275

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  46 in total

1.  Functional analysis of RET with Hirschsprung mutations affecting its kinase domain.

Authors:  T Iwashita; K Kurokawa; S Qiao; H Murakami; N Asai; K Kawai; M Hashimoto; T Watanabe; M Ichihara; M Takahashi
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease.

Authors:  Guido Fitze; Jakob Cramer; Andreas Ziegler; Mandy Schierz; Matthias Schreiber; Eberhard Kuhlisch; Dietmar Roesner; Hans K Schackert
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

3.  The RET receptor: function in development and dysfunction in congenital malformation.

Authors:  S Manié; M Santoro; A Fusco; M Billaud
Journal:  Trends Genet       Date:  2001-10       Impact factor: 11.639

4.  Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease.

Authors:  R Gath; A Goessling; K M Keller; S Koletzko; W Coerdt; H Müntefering; S Wirth; R M Hofstra; L Mulligan; C Eng; A von Deimling
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

5.  The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.

Authors:  B Mograbi; R Bocciardi; I Bourget; T Juhel; D Farahi-Far; G Romeo; I Ceccherini; B Rossi
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

6.  Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.

Authors:  G De Vita; R M Melillo; F Carlomagno; R Visconti; M D Castellone; A Bellacosa; M Billaud; A Fusco; P N Tsichlis; M Santoro
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

7.  Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.

Authors:  F Lesueur; M Corbex; J D McKay; J Lima; P Soares; P Griseri; J Burgess; I Ceccherini; S Landolfi; M Papotti; A Amorim; D E Goldgar; G Romeo
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

8.  A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease.

Authors:  P Griseri; M Sancandi; G Patrone; R Bocciardi; R Hofstra; R Ravazzolo; M Devoto; G Romeo; I Ceccherini
Journal:  Eur J Hum Genet       Date:  2000-09       Impact factor: 4.246

9.  Large-scale analysis of mutations in RET exon 16 in sporadic medullary thyroid carcinomas in Japan.

Authors:  T Takano; A Miyauchi; H Yoshida; Y Hasegawa; K Kuma; N Amino
Journal:  Jpn J Cancer Res       Date:  2001-06

10.  cDNA sequence and genomic structure of the rat RET proto-oncogene.

Authors:  I Matera; M De Miguel-Rodríguez; J M Fernández-Santos; G Santamaria; A Puliti; R Ravazzolo; G Romeo; H Galera-Davidson; I Ceccherini
Journal:  DNA Seq       Date:  2000
View more
  1 in total

1.  RET gene is a major risk factor for Hirschsprung's disease: a meta-analysis.

Authors:  C Tomuschat; P Puri
Journal:  Pediatr Surg Int       Date:  2015-07-12       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.